The CD4+CD25+ regulatory T cells (Tregs) and their effector molecule FGL2 play a key role in susceptibility to HBV infection and in regulating the outcome of fulminant viral hepatitis in vivo [11]. Here, FGL2 is linked to animal viral hepatitis.